Withdrawal of inhaled corticosteroids from patients with copd with mild or moderate airflow limitation in primary care: a feasibility randomised trial

HIGHLIGHTS

• who: Timothy H Harries and collaborators from the School of Population Health London, UK PCPS, University of have published the research work: Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial, in the Journal: BMJ Open Resp Res 2022;9:e001311. of 18/05/2022
• what: The authors examined the feasibility and accuracy of identifying patients with true COPD and mild or moderate airflow limitation and low exacerbation history from existing general practice health records, the acceptability of randomisation to withdrawal of ICS . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.